Saikosaponin A inhibits compound 48/80-induced pseudo-allergy via the Mrgprx2 pathway in vitro and in vivo
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 148, 147-154
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81230079, 81227802, 81503321)
- China Postdoctoral Science Foundation (2016M592808)
- Natural Science Foundation of Shaanxi Province (2016JQ8025)
This publication has 21 references indexed in Scilit:
- Saikosaponin a inhibits RANKL-induced osteoclastogenesis by suppressing NF-κB and MAPK pathwaysInternational Immunopharmacology, 2015
- Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactionsNature, 2014
- Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxisBiochemical Pharmacology, 2014
- Attenuation of Neuropathic Pain by Saikosaponin a in a Rat Model of Chronic Constriction InjuryNeurochemical Research, 2014
- Saikosaponin A of Bupleurum chinense (Chaihu) elevates bone morphogenetic protein 4 (BMP-4) during hepatic stellate cell activationPhytomedicine, 2013
- Anti‐allergic action of anti‐malarial drug artesunate in experimental mast cell‐mediated anaphylactic modelsAllergy, 2012
- G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: Roles of Mas-related genes MrgX1 and MrgX2European Journal of Pharmacology, 2011
- Anaphylaxis: mechanisms and managementClinical & Experimental Allergy, 2011
- Effect of saikosaponin‐A, a triterpenoid glycoside, isolated from Bupleurum falcatum on experimental allergic asthmaPhytotherapy Research, 2002
- A Diverse Family of GPCRs Expressed in Specific Subsets of Nociceptive Sensory NeuronsCell, 2001